The January 30 issue of BusinessWeek has a good article on the high cost of cancer treatments. For example, Genentech's Avastin, which can add months to the lives of patients suffering colon, lung or breast cancer, can cost from $4,400 to $8,800 per month. And despite the positive effects of these drugs, the makers have no incentive to make them more affordable.
- BusinessWeek: Going Broke to Stay Alive
Comments